Mkts

Harvard Bioscience, Inc.

NASDAQ: HBIO
$9.08+0.17 (+1.91%)
As of Nov 17, 4:00 PM ET

Key statistics

Day range
8.829.58
52-week range
4.0010.20
Today
Open9.00
Previous close9.08
Volume340
Valuation
Market cap42.07M
P/E ratio—
EPS (TTM)-2.32
Income & risk
Dividend / yield—
Beta1.44
Avg volume20.3K
Discussion

HBIO News

Stories mentioning HBIO from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue20,75523,73520,59120,45021,77424,55621,97023,097
Cost of Goods Sold8,5119,5638,5708,9179,59010,5459,2059,879
Gross Profit12,24414,17212,02111,53312,18414,01112,76513,218
Operating Expenses
Research & Development2,3262,1832,1322,1892,3212,3282,5672,626
Sales General & Admin
Total Operating Expenses13,41812,46211,82412,35261,85214,00014,63915,287
Operating Income (Loss)(1,174)1,710197.00(819.00)(49,668)11.00(1,874)(2,069)
Interest Income
Interest Expense
Other Expense(405.00)(1,454)(365.00)(644.00)(193.00)516.00(518.00)(181.00)
Pretax Income(3,307)(3,204)(1,134)(2,254)(50,794)590.00(4,491)(3,280)
Tax Provision117.00(357.00)97.0028.00(454.00)572.00311.00(353.00)
Net Income (Loss)(3,424)(2,847)(1,231)(2,282)(50,340)18.00(4,802)(2,927)
Earnings Per Share (Basic)(0.77)(0.06)(0.03)(0.05)(11.42)0.00(0.11)(0.07)
Earnings Per Share (Diluted)(0.77)(0.06)(0.03)(0.05)(11.42)0.00(0.11)(0.07)
Weighted Average Shares Outstanding (Basic)4,47344,39144,55644,3034,41043,53843,61443,486
Weighted Average Shares Outstanding (Diluted)4,47344,39144,55644,3034,41043,53843,61443,486

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About HBIO

Harvard Bioscience, Inc. (NASDAQ: HBIO) is a stock listed on the Nasdaq Stock Market under the ticker symbol HBIO. It last traded at $9.08 (Nov 17, 2026, 4:00 PM ET), up 1.9% on the day. That gives Harvard Bioscience a market capitalisation of $42.1M.

Over the past 52 weeks HBIO has traded between $4.00 and $10.20.

Revenue for the quarter ended Mar 31, 2026 was $20.8M; a net loss of $3.4M. Revenue was down 4.7% from $21.8M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$20.8M-$3.4M-16.5%
Dec 31, 2025$23.7M-$2.8M-12.0%
Sep 30, 2025$20.6M-$1.2M-6.0%
Jun 30, 2025$20.5M-$2.3M-11.2%

From Harvard Bioscience’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…